These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 3708774)

  • 61. Electrophysiologic studies in a patient with atrial flutter and 1:1 atrioventricular conduction.
    Aranda JM; Moleiro F; Castellanos A; Befeler B
    Chest; 1975 Aug; 68(2):200-4. PubMed ID: 1149548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prolongation of refractoriness and activation time in normal canine ventricular myocardium following bolus administration of lidocaine.
    Martins JB; Kelly KJ
    Am Heart J; 1985 Mar; 109(3 Pt 1):533-9. PubMed ID: 3976480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of class IA antiarrhythmic drugs on the reentrant circuit in common human atrial flutter.
    Ohga N; Inoue T; Doi T; Yoshida A; Yokoyama M
    Jpn Circ J; 1995 Dec; 59(12):799-807. PubMed ID: 8788371
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination of sotalol and quinidine in a canine model of torsades de pointes: no increase in the QT-related proarrhythmic action of sotalol.
    Chézalviel-Guilbert F; Deplanne V; Davy JM; Poirier JM; Xia YZ; Cheymol G; Weissenburger J
    J Cardiovasc Electrophysiol; 1998 May; 9(5):498-507. PubMed ID: 9607458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model.
    Ortiz J; Igarashi M; Gonzalez HX; Laurita K; Rudy Y; Waldo AL
    Circulation; 1993 Oct; 88(4 Pt 1):1866-77. PubMed ID: 8403332
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of electrical heterogeneity impairs ventricular defibrillation: an effect specific to regional conduction velocity slowing.
    Ujhelyi MR; Sims JJ; Miller AW
    Circulation; 1999 Dec 21-28; 100(25):2534-40. PubMed ID: 10604892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A logical state model of circus movement atrial flutter role of anatomic obstacles, anisotropic conduction and slow conduction zones on induction, sustenance, and overdrive paced modulation of reentrant circuits.
    Yang H; el-Sherif N; Isber N; Restivo M
    IEEE Trans Biomed Eng; 1994 Jun; 41(6):537-48. PubMed ID: 7927373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model.
    Kumagai K; Nakashima H; Gondo N; Saku K
    J Cardiovasc Electrophysiol; 2003 Aug; 14(8):880-4. PubMed ID: 12890053
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Circus movement in the canine atrium around the tricuspid ring during experimental atrial flutter and during reentry in vitro.
    Frame LH; Page RL; Boyden PA; Fenoglio JJ; Hoffman BF
    Circulation; 1987 Nov; 76(5):1155-75. PubMed ID: 3665000
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.
    Juul-Möller S; Edvardsson N; Rehnqvist-Ahlberg N
    Circulation; 1990 Dec; 82(6):1932-9. PubMed ID: 2242519
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent.
    Lathrop DA; Varró A
    Br J Pharmacol; 1990 Jan; 99(1):124-30. PubMed ID: 2331566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Atrial vulnerability and electrophysiology determined in patients with and without paroxysmal atrial fibrillation.
    Kühlkamp V; Haasis R; Seipel L
    Pacing Clin Electrophysiol; 1992 Jan; 15(1):71-80. PubMed ID: 1371003
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans.
    Newman D; Dorian P; Feder-Elituv R
    Can J Physiol Pharmacol; 1993; 71(10-11):755-60. PubMed ID: 8143233
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiac electrophysiologic effects of quinidine and propranolol isomers in anesthetized dogs: concentration-response relationships.
    Jaillon P; Heckle J; Aubry JP; Weissenburger J; Cheymol G
    J Cardiovasc Pharmacol; 1981; 3(3):431-45. PubMed ID: 6168825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
    Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reentrant tachycardia in a thin layer of ventricular subepicardium: effects of d-sotalol and lidocaine.
    Hill BC; Hunt AJ; Courtney KR
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):871-80. PubMed ID: 1704978
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity.
    Hayward RP; Taggart P
    Cardiovasc Res; 1986 Feb; 20(2):100-7. PubMed ID: 3708643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.